Berkshire Asset Management LLC Abbott Laboratories Transaction History

Berkshire Asset Management LLC

$2 Billion
Q2 2024

A detailed history of Berkshire Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Berkshire Asset Management LLC holds 306,128 shares of ABT stock, worth $34.5 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

306,128

Previous 288,697 6.04%

Holding current value

$34.5 Million

Previous $32.8 Million 3.06%

% of portfolio

1.59%

Previous 1.74%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.76 Million - $1.96 Million	17,431 Added 6.04%	306,128 $31.8 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $87,177 - $96,284	796 Added 0.28%	288,697 $32.8 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $89,829 - $109,958	-996 Reduced 0.34%	287,901 $31.7 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $190,486 - $228,552	-1,994 Reduced 0.69%	288,897 $28 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $643,883 - $717,420	6,389 Added 2.25%	290,891 $31.7 Million
Q1 2023 Jun 06, 2023	SELL	$96.86 - $114.01 $230,623 - $271,457	-2,381 Reduced 0.83%	284,502 $28.8 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $847,459 - $994,200	8,915 Added 3.21%	286,883 $31.5 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $196,713 - $227,756	-2,033 Reduced 0.73%	277,968 $26.9 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $661,923 - $800,054	6,485 Added 2.37%	280,001 $30.4 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $486,523 - $593,283	4,267 Added 1.58%	273,516 $32.4 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $376,281 - $460,735	-3,257 Reduced 1.2%	269,249 $37.9 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $150,841 - $166,874	1,293 Added 0.48%	272,506 $32.2 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.25 Million - $1.47 Million	11,814 Added 4.55%	271,213 $31.4 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $1.95 Million - $2.3 Million	-17,908 Reduced 6.46%	259,399 $31.1 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.79 Million - $1.95 Million	17,055 Added 6.55%	277,307 $30.4 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $2.16 Million - $2.63 Million	-23,611 Reduced 8.32%	260,252 $28.3 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $590,354 - $755,580	7,710 Added 2.79%	283,863 $26 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $12,438 - $18,188	-198 Reduced 0.07%	276,153 $21.8 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $845,631 - $941,385	-10,771 Reduced 3.75%	276,351 $24 Million
Q3 2019 Oct 07, 2019	BUY	$81.84 - $88.74 $328,914 - $356,646	4,019 Added 1.42%	287,122 $24 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $169,081 - $197,200	-2,320 Reduced 0.81%	283,103 $23.8 Million
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $106,812 - $129,136	-1,613 Reduced 0.56%	285,423 $22.8 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $76,115 - $86,227	-1,161 Reduced 0.4%	287,036 $20.8 Million
Q3 2018 Oct 12, 2018	BUY	$60.81 - $73.36 $735,922 - $887,802	12,102 Added 4.38%	288,197 $21.1 Million
Q2 2018 Jul 17, 2018	BUY	$57.57 - $63.54 $82,440 - $90,989	1,432 Added 0.52%	276,095 $16.8 Million
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $168,472 - $190,478	2,994 Added 1.1%	274,663 $16.5 Million
Q4 2017 Jan 17, 2018	BUY	$53.68 - $57.47 $1.25 Million - $1.33 Million	23,214 Added 9.34%	271,669 $15.5 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $11.9 Million - $13.3 Million	248,455	248,455 $13.3 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Account

Berkshire Asset Management LLC Abbott Laboratories Transaction History